← Back to Clinical Trials
Recruiting NCT07167849

NCT07167849 Study on a Digital Ultra-Brief Intervention During Wait Times for Psychotherapy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07167849
Status Recruiting
Phase
Sponsor University of Bern
Condition Depressive Disorders
Study Type INTERVENTIONAL
Enrollment 312 participants
Start Date 2025-09-22
Primary Completion 2027-12

Trial Parameters

Condition Depressive Disorders
Sponsor University of Bern
Study Type INTERVENTIONAL
Phase N/A
Enrollment 312
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-09-22
Completion 2027-12
Interventions
UKADO Content - problem-focusedUKADO Content - resource-focusedHuman support

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The OPTIBRIEF study investigates different versions of a digital ultra-brief intervention (UKADO - a German acronym for ultra-brief intervention against anxiety and depression online) during the waiting period for psychotherapy. Using a factorial trial design, the components 1) intervention content, 2) human support, and 3) expectation-fostering elements will be examined. After completing initial questionnaires and participating in a diagnostic interview, participants are randomly assigned to one of eight groups and work through a specific version of UKADO. The program can be completed in a session of approximately 60 minutes, after which the exercises should continue to be used. Participants then complete another set of questionnaires at specific time points (after 2 weeks, 5 weeks, 9 weeks, and 24 weeks). A selection of participants also takes part in another telephone appointment to assess experiences with UKADO. With the OPTIBRIEF study, the investigators aim to determine which version of the program is most suitable for individuals waiting for a psychotherapy slot. To this end, the investigators examine the effects on anxiety and depression symptom severity, as well as aspects such as participants' experiences with the program.

Eligibility Criteria

Inclusion Criteria: * Read the patient information and return signed written informed consent sheet * Currently waiting for outpatient psychotherapy (self-report at baseline and assessed per telephone) * Age ≥ 18 (self-report at baseline and assessed per telephone) * Scoring equal to or above 10 on the PHQ-ADS (self-report at baseline) * Fulfilling diagnostic criteria of one or more of the following disorders assessed with the Diagnostic Short-Interview for Mental Disorders (Mini-DIPS, DSM-5 version; Margraf et al., 2017): Major Depressive Disorder, Persistent Depressive Disorder, Social Anxiety Disorder, Panic Disorder, Agoraphobia, Generalized Anxiety Disorder * Sufficient German skills (self-report at baseline) * Access to the internet (self-report at baseline) Exclusion Criteria: * Acute suicidality assessed during the telephone interview (Mini-DIPS) * Currently taking part in psychotherapy or a scheduled start of psychotherapy prior to the assessment 14 days post-randomization (as

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology